Protara Therapeutics, Inc.
TARA
$3.11
$0.010.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 122.22M | 124.36M | 170.29M | 81.50M | 89.58M |
| Total Receivables | 890.00K | 368.00K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 628.00K | 891.00K | 928.00K | 940.00K | 1.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.36M | 910.00K | 935.00K | 2.64M | 1.58M |
| Total Current Assets | 125.09M | 126.53M | 172.16M | 85.08M | 92.21M |
|
|
|||||
| Total Current Assets | 125.09M | 126.53M | 172.16M | 85.08M | 92.21M |
| Net Property, Plant & Equipment | 4.64M | 4.98M | 5.28M | 5.62M | 5.95M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.81M | 3.89M | 4.02M | 3.39M | 3.48M |
| Total Assets | 156.93M | 168.56M | 181.45M | 94.09M | 101.65M |
|
|
|||||
| Total Accounts Payable | 5.30M | 2.31M | 4.43M | 2.30M | 1.39M |
| Total Accrued Expenses | 3.26M | 3.54M | 5.41M | 5.27M | 3.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.20M | 1.17M | 1.12M | 1.08M | 1.04M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.76M | 7.02M | 10.96M | 8.64M | 5.65M |
|
|
|||||
| Total Current Liabilities | 9.76M | 7.02M | 10.96M | 8.64M | 5.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.75M | 3.06M | 3.36M | 3.66M | 3.95M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.51M | 10.08M | 14.32M | 12.30M | 9.60M |
|
|
|||||
| Common Stock & APIC | 416.20M | 415.29M | 412.11M | 313.97M | 313.04M |
| Retained Earnings | -271.85M | -256.89M | -244.98M | -232.21M | -220.99M |
| Treasury Stock & Other | 77.00K | 89.00K | 2.00K | 29.00K | -- |
| Total Common Equity | 144.42M | 158.48M | 167.13M | 81.79M | 92.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 144.42M | 158.48M | 167.13M | 81.79M | 92.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 144.42M | 158.48M | 167.13M | 81.79M | 92.05M |
|
|
|||||